Blue Buffalo faces class action over grain-free dog food claims: full analysis
A new proposed class action against Blue Buffalo is putting grain-free dog food back under a legal and clinical spotlight. According to trade and local media reports, a Lake County, Illinois, family alleges Blue Buffalo’s grain-free products contributed to their dog’s development of dilated cardiomyopathy and ultimate death, while the company continued to market those diets as healthy, natural, and worth a premium price. (petfoodindustry.com)
The case taps into a debate that has been running for years inside companion animal medicine. In July 2018, the FDA said it was investigating reports of canine DCM in dogs eating certain diets, many labeled grain-free and containing high proportions of peas, lentils, other pulses, and potatoes. The agency later updated that work several times, but in its most recent public update, it said adverse event reports by themselves do not provide sufficient data to establish a causal relationship with specific products. (fda.gov)
Even so, the issue hasn’t gone away in clinical practice. AAHA’s nutrition guidance continues to address diet-associated DCM as a real concern for veterinarians evaluating dogs with murmurs, arrhythmias, exercise intolerance, or other signs of heart disease. Tufts nutrition commentary has likewise argued that the condition remains relevant even though the precise mechanism is still unresolved, and that concern extends beyond a simple grain-free versus grain-inclusive framing. (aaha.org)
In the Blue Buffalo case, reports say the plaintiffs are seeking to represent a nationwide class of consumers who bought the company’s grain-free dog food and allegedly paid more because of health-related marketing claims. PetfoodIndustry reported that the complaint leans on both scientific literature and the FDA’s earlier investigation into diet-related DCM, while CBS Chicago reported the family’s dog, Maya, died in 2024 at age 10. A Law360 docket listing indicates the case is captioned Walsh et al. v. Blue Buffalo Co., Ltd., though full court filings were not readily available in the sources reviewed. (petfoodindustry.com)
There’s also broader legal context here. Blue Buffalo has faced prior litigation over pet food marketing and labeling, including earlier multidistrict litigation over ingredient representations. PetfoodIndustry recently pointed to similar DCM-related cases involving other pet food brands, suggesting plaintiffs’ attorneys are testing whether diet-associated DCM claims can gain traction in court even as the science remains contested and incomplete. (moed.uscourts.gov)
Expert reaction in this latest case was limited in the sources reviewed, but the veterinary backdrop is clear: specialists and guidance documents continue to recommend careful diet histories and case-by-case evaluation rather than blanket assumptions. That’s important because the FDA’s position is narrower than many public summaries suggest. The agency has not closed the book on the issue; it has said the available adverse event data are insufficient on their own to prove causation, and it does not plan further public updates unless meaningful new scientific information emerges. (fda.gov)
Why it matters: For veterinary teams, the immediate impact is less about the courtroom than the consult room. High-profile litigation can drive anxious calls from pet parents, increase pressure for definitive answers, and blur the difference between signal, suspicion, and proof. Practices may want to revisit how they document diet history, explain the current evidence on diet-associated DCM, and decide when to recommend echocardiography, taurine testing, or diet changes in dogs with compatible histories or clinical signs. (aaha.org)
What to watch: The next milestones are Blue Buffalo’s formal response, whether the plaintiffs can move the case toward class certification, and whether this suit influences product marketing, retailer conversations, or renewed professional guidance around grain-free and pulse-heavy canine diets. (petfoodindustry.com)